Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Oncology

AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?

AbbVie's early 2026 price pullback is an irresistable opportunity for buy-and-hold investors looking for income and compounding opportunities.

MarketBeat

Pfizer Stock Edges Higher as Oncology Wins and Pipeline Bets Fuel Optimism Amid Flat 2026 Outlook

Pfizer Inc. shares ticked up modestly Tuesday as investors weighed fresh positive oncology data against the pharmaceutical giant's flat revenue guidance for 2026 and ongoing pressures from declining COVID-19 product sales.

International Business Times

Merck Just Made a Big Bet on a New Cancer Growth Engine

Merck's $6.7 billion Terns acquisition bolsters its oncology pipeline while reinforcing its strong margins, steadily growing dividend, and long-term growth.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Investors Have Been Waiting to Buy the Dip in This Hot Biopharma Stock

Jazz Pharmaceuticals (JAZZ) is a specialty biopharma company focused on neuroscience and oncology. JAZZ exhibits strong technical momentum. Shares are up nearly 50% over the past year. The stock maintains a 100% “Buy” technical opinion from Barchart. Wall Street sentiment is bullish with multiple “Strong Buy” ratings and price targets...

Barchart

Repurposed Antiparasitic Drugs in Cancer Research: What the Science Says About Fenbendazole and Mebendazole

The concept of drug repurposing has gained substantial momentum in oncology research over the past several years. Among the most discussed candidates in this emerging field are benzimidazole antiparasitic agents, particularly fenbendazole.

Medical Daily

Decoding the Warning Signs: 10 Behaviour Changes Demanding Attention

Pets communicate through actions and it holds true for happiness as well as distress. Dr. Abhishek Choudhary, Veterinarian, Vetic, looks at 10 common behaviour changes that can signal illness, discomfort, or ageing-related issues in pets. He will also explain why prompt veterinary care is essential when you notice these signs…

Times Pets

Little Heroes: EU Parliament pays tribute to child cancer victims with Brussels art exhibition

Part of the European Parliament in Brussels has been transformed into a glowing artistic tribute space this week to display colourful paintings from the Children's Oncology Unit of Makareio Hospital in Cyprus

Euronews

Read news from The Economist, FT, and more,
with one subscription

Free HPV Vaccine for Girls What Parents Need to Know

Human Papillomavirus or HPV is a group of more than 100 related viruses, some of which are classified as high risk types because they can cause cancer. Persistent infection with high risk HPV strains, particularly HPV 16 and HPV 18, is responsible for the majority of cervical cancer cases globally.…

MyLifeXP

'Cuba's healthcare system is being pushed to the brink by US blockades,' says health minister

Cuba’s Health Minister says the country is headed to a catastrophic humanitarian crisis, saying the US blockade of oil on his country is rendering hospitals helpless and puts thousands of lives at risk.

Euronews

Who is Kashyap Patel? Indian-origin doctor wins prestigious NRI award Hind Rattan for transforming cancer care

Kashyap Patel, an Indian-origin physician, has been honored with the prestigious Hind Rattan Award for his two decades of work in community oncology. He is recognized for championing equitable access to high-quality cancer care, particularly for rural and underserved populations, and advocating for patient-centered treatment beyond major urban hospitals.

The Times of India

1 Under-$10 Stock Set to Surge as Much as 850% in 2026

Kura is a classic high-risk, high-reward biotech investment that has entered a vital growth phase.

Barchart

Exelixis Reports Solid Earnings—Are New Highs Back on the Table?

Exelixis beats earnings estimates as Cabometyx drives profits and zanzalintinib positions the biotech for a major oncology expansion

MarketBeat

Pfizer Pops on Q4 Results—But This May Be the Catalyst That Matters Most

Pfizer stock jumped after a strong earnings beat and positive GLP-1 data, but investors may be overlooking a powerful oncology and AI-driven growth story.

MarketBeat

'We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology

"The winners in life are differentiated from the losers in life because the winners never fall," Albert Bourla says. "The winners always stand up again."

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

A Fresh IPO That Long-Term Investors Shouldn’t Ignore

Aktis Oncology, which recently had its IPO, has gained substantial backing from Big Pharma mainstay Eli Lilly. Investors should take note of the biotech firm.

International Business Times

Inside CTOAM's Precision Oncology Approach and Its Focus on Advanced Diagnostics With Individual Cancer Patients' Needs

At the core of CTOAM's work, Morand explains, is a precision oncology process that integrates multiple diagnostic tools into a single, coordinated pathway. The company supports tumor DNA and RNA sequencing, whole genome liquid biopsies for real-time monitoring, and advanced imaging, including PET-CT scans, depending on what each individual case…

MarketBeat

Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake

With activist investors gone and revenue stabilizing, the undervalued pharmaceutical giant offers a compelling chance for value investors in the coming year.

Barchart

This Growth Stock With 137% Upside Faces New Challenge: Buy, Hold or Sell?

Not a collapse, just a pivot toward what matters most. Arcus Biosciences still has plenty of potential.

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Cancer Early Symptoms You Shouldn't Ignore: A Powerful Oncology Awareness Guide

Discover key cancer early symptoms, boost oncology awareness, and learn when to seek medical help to support earlier detection, timely diagnosis, and better treatment outcomes.

Barchart

This Oncology Stock Just Hit New All-Time Highs

Revolution Medicines (RVMD) is trading at fresh all-time highs. RVMD exhibits strong technical momentum with a 100% technical “Buy” opinion from Barchart. Shares are up nearly 60% over the past year. Wall Street analysts are overwhelmingly bullish on RVMD, although sentiment is mixed across other platforms. Today’s Featured Stock Valued...

Barchart

This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs

Burning Rock Biotech (BNR) , a precision oncology company from China, has shown exceptional technical momentum and price appreciation. BNR has surged 405% over the past year, hitting a 2-year high on Wednesday. Despite strong technicals, BNR is a highly speculative and risky stock. Today’s Chart of the Day is...

AAP

Oncology company reports promising cancer find

Shares in Kazia Therapeutics have risen more than 50 per cent after its drug candidate appeared to successfully treat a woman with stage-four breast cancer.

The Independent UK

‘It would be cheaper if I died:’ Cancer patients are battling insurance companies for their lives

IN FOCUS: EXCLUSIVE: Cancer patients, oncologists and advocates tell Rhian Lubin why the US health insurance system needs urgent reform, and is risking the lives of Americans fighting the disease

Benzinga

Moderna Q3 2025 Earnings Call Transcript

Moderna, Inc (NASDAQ:MRNA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below. MRNA is building positive momentum. Watch the momentum here This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visithttps://www.benzinga.com/apis/for a consultation. Operator…

inkl

Promising Therapies Extend Survival in Stage 4 Breast Cancer

Stage 4 breast cancer is also known as metastatic breast cancer. As the research evidence reports, it is the most advanced form of the disease.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Parliament

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.